144 related articles for article (PubMed ID: 38643112)
1. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
[TBL] [Abstract][Full Text] [Related]
2. The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal adenocarcinoma.
Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
Updates Surg; 2021 Feb; 73(1):251-259. PubMed ID: 32410163
[TBL] [Abstract][Full Text] [Related]
3. Controlling Nutritional Status score is superior to Prognostic Nutritional Index score in predicting survival and complications in pancreatic ductal adenocarcinoma: a Chinese propensity score matching study.
Mao YS; Hao SJ; Zou CF; Xie ZB; Fu DL
Br J Nutr; 2020 Dec; 124(11):1190-1197. PubMed ID: 32594921
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment.
Tamai Y; Iwasa M; Eguchi A; Shigefuku R; Sugimoto R; Tanaka H; Kobayashi Y; Mizuno S; Nakagawa H
Eur J Gastroenterol Hepatol; 2022 Dec; 34(12):1269-1276. PubMed ID: 36317773
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Controlling Nutritional Status Score on the Prognosis After Curative Resection of Pancreatic Ductal Adenocarcinoma.
Kato Y; Yamada S; Suenaga M; Takami H; Niwa Y; Hayashi M; Iwata N; Kanda M; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kodera Y
Pancreas; 2018 Aug; 47(7):823-829. PubMed ID: 29975352
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
[TBL] [Abstract][Full Text] [Related]
7. Low psoas muscle index is a poor prognostic factor for lower gastrointestinal perforation: a single-center retrospective cohort study.
Kayano H; Nomura E; Abe R; Ueda Y; Machida T; Fujita C; Uchiyama S; Endo K; Murakami K; Mukai M; Makuuchi H
BMC Surg; 2019 Nov; 19(1):181. PubMed ID: 31779610
[TBL] [Abstract][Full Text] [Related]
8. Impact of Preoperative Skeletal Muscle Mass and Nutritional Status on Short-and Long-Term Outcomes After Esophagectomy for Esophageal Cancer: A Retrospective Observational Study : Impact of Psoas Muscle Mass and Body Mass on Esophagectomy.
Shichinohe T; Uemura S; Hirano S; Hosokawa M
Ann Surg Oncol; 2019 May; 26(5):1301-1310. PubMed ID: 30725311
[TBL] [Abstract][Full Text] [Related]
9. Psoas muscle mass, nutritional status, inflammation, and their relationship with prognosis in patients with pancreatic adenocarcinoma.
Yıldırım İ; Kaya T; İşsever K; Genç AC; Karacan A; Önmez A; Hacıbekiroğlu İ
Nutr Hosp; 2021 Oct; 38(5):1009-1015. PubMed ID: 34223769
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of a Nutritional Index Including Muscle Volume in Stage 4 Colorectal Cancer.
Nagata T; Nakase Y; Nakamura K; Sougawa A; Mochiduki S; Kitai S; Inaba S
In Vivo; 2016 11-12; 30(6):885-891. PubMed ID: 27815476
[TBL] [Abstract][Full Text] [Related]
11. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
[TBL] [Abstract][Full Text] [Related]
13. The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population.
Shen XD; Wang X; Zheng ZJ; Chen YH; Tan CL; Liu XB; Ke NW
Cancer Med; 2023 May; 12(9):10438-10448. PubMed ID: 36938648
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of CONUT score combined with serum CA199 levels in postoperative survival of patients with pancreatic ductal adenocarcinoma: a retrospective study.
Wang A; Sun B; Wang M; Shi H; Huang Z; He T; Li Q; Deng J; Fu W; Jiang Y
PeerJ; 2020; 8():e8811. PubMed ID: 32219033
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study.
Itoh S; Tsujita E; Fukuzawa K; Sugimachi K; Iguchi T; Ninomiya M; Maeda T; Kajiyama K; Adachi E; Uchiyama H; Utsunomiya T; Ikeda Y; Maekawa S; Toshima T; Harada N; Yoshizumi T; Mori M
Pancreatology; 2021 Oct; 21(7):1356-1363. PubMed ID: 34426076
[TBL] [Abstract][Full Text] [Related]
16. Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy.
Takaichi S; Tomimaru Y; Kobayashi S; Toya K; Sasaki K; Iwagami Y; Yamada D; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
Ann Surg Oncol; 2023 Apr; 30(4):2458-2468. PubMed ID: 36575288
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Preoperative Nutritional and Immunological Factors in Patients with Pancreatic Ductal Adenocarcinoma.
Abe T; Nakata K; Kibe S; Mori Y; Miyasaka Y; Ohuchida K; Ohtsuka T; Oda Y; Nakamura M
Ann Surg Oncol; 2018 Dec; 25(13):3996-4003. PubMed ID: 30225838
[TBL] [Abstract][Full Text] [Related]
18. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
19. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with pancreatic cancer undergoing radical surgery.
Dang C; Wang M; Zhu F; Qin T; Qin R
Asian J Surg; 2022 Jun; 45(6):1237-1245. PubMed ID: 34493426
[TBL] [Abstract][Full Text] [Related]
20. Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study.
Murakawa M; Yamamoto N; Kamioka Y; Kamiya M; Kobayashi S; Ueno M; Morimoto M; Atsumi Y; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S
In Vivo; 2020; 34(1):347-353. PubMed ID: 31882498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
